A Amouzougan1,2, A Deygat1,2, B Trombert3,4, E Constant1,2, D Denarié1,2, H Marotte1,2, T Thomas5,6. 1. INSERM U1059, Lab Biologie Intégrée du Tissu Osseux, Université de Lyon, Lyon, France. 2. Rheumatology Department, University Hospital of Saint-Etienne, 42023, Saint-Etienne, France. 3. SSPIM, University Hospital of Saint-Etienne, Saint-Etienne, France. 4. EA SNA-EPIS, PRES Lyon, Saint-Etienne, France. 5. INSERM U1059, Lab Biologie Intégrée du Tissu Osseux, Université de Lyon, Lyon, France. thierry.thomas@chu-st-etienne.fr. 6. Rheumatology Department, University Hospital of Saint-Etienne, 42023, Saint-Etienne, France. thierry.thomas@chu-st-etienne.fr.
Abstract
UNLABELLED: In a population of postmenopausal women with a fragility fracture, we found a drastic reduction in the proportion of women with severe (<25 nmol/L) and moderate (25 to 75 nmol/L) hypovitaminosis D, especially from 2009 onwards. These results show that supplementation has been very widely integrated into current practice. INTRODUCTION: Vitamin D (25(OH)D) is essential for bone health. In institutionalised osteoporotic women, it reduces the risk of fragility fractures. Numerous articles suggesting the possibility of extraosseous effects have generated a growing number of publications and recommendations on more widespread administration, to limit the risks of moderate or severe hypovitaminosis D. We assessed the impact on clinical practice of these recommendations concerning 25(OH)D supplementation in elderly at-risk populations. METHODS: A total of 1486 postmenopausal osteoporotic women were seen in the context of a fracture liaison service (i.e. a rheumatology consultation following a peripheral fragility fracture), between May 2005 and December 2012. Of these, 1107 had a 25(OH)D assay (femur, n = 520; humerus, n = 207; wrist, n = 380). RESULTS: The average age of the total population was 76.7 ± 9.9 years, while for women with an available 25(OH)D assay, the average age was 75.1 ± 11.8 years. The average 25(OH)D (nmol/L) level was similar for the three fracture sites: femur, 30 ± 36.2; humerus, 27.5 ± 24; and wrist, 31 ± 26. A drastic reduction in the proportion of women with severe (<25 nmol/L) and moderate (25 to 75 nmol/L) hypovitaminosis D was observed, especially from 2009 onwards, with a mean prevalence of 69 and 30 % respectively before that year and 35 and 52 % thereafter. Conversely, the proportion of women with 25(OH)D at the threshold value of 75 nmol/L increased from 1.2 to 24 %. Overall, mean serum 25(OH)D levels were significantly higher when comparing the two periods 2005-2008 and 2009-1012 (17.6 ± 14.6 and 48.4 ± 39.2 nmol/L, respectively; p < 0.0001). CONCLUSION: These results show that supplementation has been very widely integrated into current practice. We can expect it to yield beneficial effects in osseous and extraosseous terms in osteoporotic women, particularly the very elderly.
UNLABELLED: In a population of postmenopausal women with a fragility fracture, we found a drastic reduction in the proportion of women with severe (<25 nmol/L) and moderate (25 to 75 nmol/L) hypovitaminosis D, especially from 2009 onwards. These results show that supplementation has been very widely integrated into current practice. INTRODUCTION:Vitamin D (25(OH)D) is essential for bone health. In institutionalised osteoporoticwomen, it reduces the risk of fragility fractures. Numerous articles suggesting the possibility of extraosseous effects have generated a growing number of publications and recommendations on more widespread administration, to limit the risks of moderate or severe hypovitaminosis D. We assessed the impact on clinical practice of these recommendations concerning 25(OH)D supplementation in elderly at-risk populations. METHODS: A total of 1486 postmenopausal osteoporoticwomen were seen in the context of a fracture liaison service (i.e. a rheumatology consultation following a peripheral fragility fracture), between May 2005 and December 2012. Of these, 1107 had a 25(OH)D assay (femur, n = 520; humerus, n = 207; wrist, n = 380). RESULTS: The average age of the total population was 76.7 ± 9.9 years, while for women with an available 25(OH)D assay, the average age was 75.1 ± 11.8 years. The average 25(OH)D (nmol/L) level was similar for the three fracture sites: femur, 30 ± 36.2; humerus, 27.5 ± 24; and wrist, 31 ± 26. A drastic reduction in the proportion of women with severe (<25 nmol/L) and moderate (25 to 75 nmol/L) hypovitaminosis D was observed, especially from 2009 onwards, with a mean prevalence of 69 and 30 % respectively before that year and 35 and 52 % thereafter. Conversely, the proportion of women with 25(OH)D at the threshold value of 75 nmol/L increased from 1.2 to 24 %. Overall, mean serum 25(OH)D levels were significantly higher when comparing the two periods 2005-2008 and 2009-1012 (17.6 ± 14.6 and 48.4 ± 39.2 nmol/L, respectively; p < 0.0001). CONCLUSION: These results show that supplementation has been very widely integrated into current practice. We can expect it to yield beneficial effects in osseous and extraosseous terms in osteoporoticwomen, particularly the very elderly.
Authors: J-C Souberbielle; D Prié; M Courbebaisse; G Friedlander; P Houillier; G Maruani; E Cavalier; C Cormier Journal: Ann Endocrinol (Paris) Date: 2008-09-18 Impact factor: 2.478
Authors: A Marra; G Leoncini; M Mussap; M Bovio; E Nazzari; M Giusti; F Minuto; G Murialdo; P Ameri Journal: Int J Clin Pract Date: 2014-02-06 Impact factor: 2.503
Authors: Roman Romero-Ortuno; Lisa Cogan; Joseph Browne; Martin Healy; Miriam Catherine Casey; Conal Cunningham; James Bernard Walsh; Rose Anne Kenny Journal: Age Ageing Date: 2010-11-03 Impact factor: 10.668
Authors: Kaberi Dasgupta; Robert R Quinn; Kelly B Zarnke; Doreen M Rabi; Pietro Ravani; Stella S Daskalopoulou; Simon W Rabkin; Luc Trudeau; Ross D Feldman; Lyne Cloutier; Ally Prebtani; Robert J Herman; Simon L Bacon; Richard E Gilbert; Marcel Ruzicka; Donald W McKay; Tavis S Campbell; Steven Grover; George Honos; Ernesto L Schiffrin; Peter Bolli; Thomas W Wilson; Patrice Lindsay; Michael D Hill; Shelagh B Coutts; Gord Gubitz; Mark Gelfer; Michel Vallée; G V Ramesh Prasad; Marcel Lebel; Donna McLean; J Malcolm O Arnold; Gordon W Moe; Jonathan G Howlett; Jean-Martin Boulanger; Pierre Larochelle; Lawrence A Leiter; Charlotte Jones; Richard I Ogilvie; Vincent Woo; Janusz Kaczorowski; Kevin D Burns; Robert J Petrella; Swapnil Hiremath; Alain Milot; James A Stone; Denis Drouin; Kim L Lavoie; Maxime Lamarre-Cliche; Guy Tremblay; Pavel Hamet; George Fodor; S George Carruthers; George B Pylypchuk; Ellen Burgess; Richard Lewanczuk; George K Dresser; S Brian Penner; Robert A Hegele; Philip A McFarlane; Milan Khara; Andrew Pipe; Paul Oh; Peter Selby; Mukul Sharma; Debra J Reid; Sheldon W Tobe; Raj S Padwal; Luc Poirier Journal: Can J Cardiol Date: 2014-02-22 Impact factor: 5.223
Authors: A Pflimlin; A Gournay; I Delabrière; C Chantelot; F Puisieux; B Cortet; J Paccou Journal: Osteoporos Int Date: 2019-06-05 Impact factor: 4.507
Authors: D Schray; C Neuerburg; J Stein; M Gosch; M Schieker; W Böcker; C Kammerlander Journal: Eur J Trauma Emerg Surg Date: 2016-07-25 Impact factor: 3.693
Authors: T Chevalley; M L Brandi; E Cavalier; N C Harvey; G Iolascon; C Cooper; D Hannouche; J-F Kaux; A Kurth; S Maggi; G Maier; K Papavasiliou; N Al-Daghri; M Sosa-Henríquez; N Suhm; U Tarantino; J-Y Reginster; R Rizzoli Journal: Osteoporos Int Date: 2021-05-20 Impact factor: 4.507